We are reporting for the first time the synthesis and application of an innovative nanometric system for the controlled topic release of melatonin in the retina. The ethylcellulose nanocapsules were characterized by diverse physicochemical techniques (scanning electron microscopy, zeta potential, hydrodynamic diameters) and an in vitro release study was done. A complete ex vivo and in vivo trans-corneal permeation and an irritation study were carried out with the new formulations in albino rabbits, to which a retinal degenerative model was induced. The results obtained demonstrate that the in vitro release of melatonin (1 mg/mL and 2 mg/mL) transported by nanocapsules is slower when compared to a solution of melatonin. Greater penetration o...
The present work investigates the effects of chitosan-hyaluronic acid-epoetin beta (CS/HA-EPOβ) nano...
Melatonin is a secretory product of the pineal gland that regulates circadian rhythm. It is also wel...
Oftalmička primjena lijeka jedan je od najvećih farmaceutsko-tehnoloških izazova, s obzirom na speci...
Nonexudative age-related macular degeneration (NE-AMD) represents the leading cause of blindness in ...
Optic neuritis and glaucoma, prevalent visual dysfunctions with potentially blinding sequels, are th...
The use of nanosized particles has emerged to facilitate selective applications in medicine. Drug-de...
Oxidative stress and inflammation play a pivotal role in ocular diseases. Resveratrol (RSV) is a nat...
Topical instillation of drugs targeting the posterior ocular segment is an expanding area of researc...
Glaucoma is characterized by increased intraocular pressure (IOP) that results in blindness if it re...
Diabetic retinopathy (DR) is a major complication of diabetes, characterized by extensive vascular p...
We are witnessing an exponential increase in the use of different nanomaterials in a plethora of bio...
Glaucoma and other optic neuropathies are characterized by a loss of retinal ganglion cells (RGCs), ...
PURPOSE: Neurodegenerative diseases such as Alzheimer’s disease (AD), glaucoma and multiple sclerosi...
Neuroprotection in glaucoma using epoetin beta (EPOβ) has yielded promising results. Our team has de...
Retinal degeneration refers to the pathological conditions affecting the ocular posterior segment, i...
The present work investigates the effects of chitosan-hyaluronic acid-epoetin beta (CS/HA-EPOβ) nano...
Melatonin is a secretory product of the pineal gland that regulates circadian rhythm. It is also wel...
Oftalmička primjena lijeka jedan je od najvećih farmaceutsko-tehnoloških izazova, s obzirom na speci...
Nonexudative age-related macular degeneration (NE-AMD) represents the leading cause of blindness in ...
Optic neuritis and glaucoma, prevalent visual dysfunctions with potentially blinding sequels, are th...
The use of nanosized particles has emerged to facilitate selective applications in medicine. Drug-de...
Oxidative stress and inflammation play a pivotal role in ocular diseases. Resveratrol (RSV) is a nat...
Topical instillation of drugs targeting the posterior ocular segment is an expanding area of researc...
Glaucoma is characterized by increased intraocular pressure (IOP) that results in blindness if it re...
Diabetic retinopathy (DR) is a major complication of diabetes, characterized by extensive vascular p...
We are witnessing an exponential increase in the use of different nanomaterials in a plethora of bio...
Glaucoma and other optic neuropathies are characterized by a loss of retinal ganglion cells (RGCs), ...
PURPOSE: Neurodegenerative diseases such as Alzheimer’s disease (AD), glaucoma and multiple sclerosi...
Neuroprotection in glaucoma using epoetin beta (EPOβ) has yielded promising results. Our team has de...
Retinal degeneration refers to the pathological conditions affecting the ocular posterior segment, i...
The present work investigates the effects of chitosan-hyaluronic acid-epoetin beta (CS/HA-EPOβ) nano...
Melatonin is a secretory product of the pineal gland that regulates circadian rhythm. It is also wel...
Oftalmička primjena lijeka jedan je od najvećih farmaceutsko-tehnoloških izazova, s obzirom na speci...